Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N. Takahashi K, et al. Emerg Infect Dis. 2022 May;28(5):998-1001. doi: 10.3201/eid2805.220197. Epub 2022 Mar 15. Emerg Infect Dis. 2022. PMID: 35290176 Free PMC article.
Post COVID-19 condition of the Omicron variant of SARS-CoV-2.
Morioka S, Tsuzuki S, Suzuki M, Terada M, Akashi M, Osanai Y, Kuge C, Sanada M, Tanaka K, Maruki T, Takahashi K, Saito S, Hayakawa K, Teruya K, Hojo M, Ohmagari N. Morioka S, et al. Among authors: takahashi k. J Infect Chemother. 2022 Nov;28(11):1546-1551. doi: 10.1016/j.jiac.2022.08.007. Epub 2022 Aug 11. J Infect Chemother. 2022. PMID: 35963600 Free PMC article.
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
Miyamoto S, Nishiyama T, Ueno A, Park H, Kanno T, Nakamura N, Ozono S, Aihara K, Takahashi K, Tsuchihashi Y, Ishikane M, Arashiro T, Saito S, Ainai A, Hirata Y, Iida S, Katano H, Tobiume M, Tokunaga K, Fujimoto T, Suzuki M, Nagashima M, Nakagawa H, Narita M, Kato Y, Igari H, Fujita K, Kato T, Hiyama K, Shindou K, Adachi T, Fukushima K, Nakamura-Uchiyama F, Hase R, Yoshimura Y, Yamato M, Nozaki Y, Ohmagari N, Suzuki M, Saito T, Iwami S, Suzuki T. Miyamoto S, et al. Among authors: takahashi k. Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2314808120. doi: 10.1073/pnas.2314808120. Epub 2023 Dec 22. Proc Natl Acad Sci U S A. 2023. PMID: 38134196 Free PMC article.
Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force.
Lee H, Chubachi S, Namkoong H, Asakura T, Tanaka H, Otake S, Nakagawara K, Morita A, Fukushima T, Watase M, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Lee H, et al. BMC Infect Dis. 2022 Dec 12;22(1):935. doi: 10.1186/s12879-022-07927-w. BMC Infect Dis. 2022. PMID: 36510172 Free PMC article.
Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study.
Morioka S, Tsuzuki S, Maruki T, Terada M, Miyazato Y, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Ashida S, Akashi M, Kuge C, Osanai Y, Tanaka K, Suzuki M, Hayakawa K, Ohmagari N. Morioka S, et al. Among authors: takahashi k. Public Health. 2023 Mar;216:39-44. doi: 10.1016/j.puhe.2023.01.008. Epub 2023 Feb 13. Public Health. 2023. PMID: 36791649 Free article.
[Etiology and diagnosis of congenital abnormalities].
Suzuki M, Takabayashi T, Takahashi K. Suzuki M, et al. Among authors: takahashi k. Kango Gijutsu. 1978 Mar;24(4):9-17. Kango Gijutsu. 1978. PMID: 246084 Japanese. No abstract available.
Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
Asayama K, Ohkubo T, Metoki H, Obara T, Inoue R, Kikuya M, Thijs L, Staessen JA, Imai Y; Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Asayama K, et al. Hypertens Res. 2012 Nov;35(11):1102-10. doi: 10.1038/hr.2012.125. Epub 2012 Aug 16. Hypertens Res. 2012. PMID: 22895063 Clinical Trial.
17,214 results
You have reached the last available page of results. Please see the User Guide for more information.